Can vitamin B12 deficiency or folate (folic acid) deficiency cause a decrease in neutrophil count?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Low B12 or Folate Alter Neutrophil Count?

Yes, both vitamin B12 and folate deficiency can cause a decrease in neutrophil count (neutropenia), along with other characteristic changes in neutrophil morphology, most notably hypersegmentation.

Mechanism and Hematologic Changes

Vitamin B12 and folate deficiencies cause megaloblastic anemia, which affects all blood cell lines, not just red blood cells 1. The neutrophil abnormalities include:

  • Neutropenia (decreased absolute neutrophil count) 2, 3
  • Hypersegmented neutrophils (neutrophils with ≥5 lobes, a hallmark finding) 4, 5
  • Dysgranulopoiesis with nuclear-cytoplasmic asynchrony 2
  • Macrocytosis (elevated MCV) that correlates with vitamin levels 5

The neutrophil lobe count specifically correlates with serum B12 concentrations 5. Research demonstrates that hypersegmentation persists for approximately 11-14 days after initiating treatment, even after neutropenia has resolved 4.

Functional Consequences

Beyond quantitative changes, vitamin B12 deficiency (but not folate deficiency) impairs neutrophil function 3:

  • Decreased metabolic activation during phagocytosis (reduced to 35-36% of normal)
  • Slightly impaired bacterial killing capacity
  • Normal phagocytosis and resting metabolism
  • These functional defects reverse with B12 replacement 3

Clinical Importance and Pitfalls

Critical caveat: The hematologic changes can be so profound that they mimic myelodysplastic syndromes or acute leukemia, with pancytopenia and hypercellular bone marrow showing blastic differentiation 6. This can lead to unnecessary aggressive workups or even consideration of chemotherapy if B12/folate deficiency is not recognized.

Key diagnostic point: Many patients with biochemically significant B12 or folate deficiency affecting hematopoiesis have normal blood counts initially 5. In one study, 73% of patients with abnormal thymidylate synthesis (indicating functional deficiency) had normal MCV, and 55% had morphologically normal bone marrow 5.

Testing and Treatment Approach

When evaluating unexplained neutropenia or cytopenias:

  1. Always check B12 and folate levels before assuming a primary hematologic malignancy
  2. Look for hypersegmented neutrophils on peripheral smear (≥5% with ≥5 lobes)
  3. Check MCV, though it may be normal in early or combined deficiencies
  4. Never treat with folic acid before excluding B12 deficiency, as this can mask B12 deficiency and precipitate subacute combined degeneration of the spinal cord 1

Treatment Response

For B12 deficiency with neutropenia:

  • Hydroxocobalamin 1 mg IM three times weekly for 2 weeks (if no neurological involvement) 1
  • Expect neutrophil count to increase significantly by day 8 of treatment 4
  • Hypersegmentation resolves more slowly (11-14 days) 4
  • Maintenance: 1 mg IM every 2-3 months lifelong 1

For folate deficiency (after excluding B12 deficiency):

  • Oral folic acid 5 mg daily for minimum 4 months 1

Important consideration: In patients with normocytic anemia and low B12/folate, vitamin replacement may only partially improve hemoglobin (≥1 g/dL improvement in 11% of cases), as underlying conditions often coexist 7. However, the functional neutrophil improvements with B12 replacement are clinically significant 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.